Online registration for this event is closed. Walk-in registrations will be accepted.
For five years, the redoubtable seniors advocacy organization AARP has published quarterly reports on the prices of brand-name drugs. These reports steadfastly announce that pharmaceutical prices have risen far more rapidly than inflation, thus increasing the financial burden on seniors--a puzzling conclusion, as many of the most expensive drugs are now available to seniors as far-cheaper generics. At this event, Murray Aitken, vice president of IMS Health, the world's largest source of drug-price and sales data, and MIT professor Ernst Berndt will explain why their research shows that average drug prices for seniors have declined, not increased, by more than 20 percent. AEI economist John E. Calfee will moderate.